Latest Breaking News On - Claritas health ventures - Page 6 : comparemela.com

Photo by Kwanchai Lerttanapunyapron/EyeEm/Getty Images PathAI, a Boston-based artificial intelligence pathology company, has closed a Series C funding round worth $165 million. The round was co-led by D1 Capital Partners and Kaiser Permanente, with additional participation from General Atlantic, Tiger Global Management, 8VC, Adage, Biospring Partners, General Catalyst, KdT Ventures, Polaris Partners, Refactor Capital, and strategic partners Bristol-Myers Squibb Company, Labcorp and Merck Global Health Innovation Fund. With the new funds, PathAI plans to accelerate product development to expand its suite of applications beyond oncology and nonalcoholic steatohepatitis. It will also seek new partnerships with pharmaceutical and diagnostic organizations.

United statesSebastian seiguerAkilesh bapuPeter barrettKouki harasakiTheresa sextonKaiser permanenteDonnacha osullivanClaritas health venturesSequoia scout fundBristol myers squibb companyMerck global health innovation fundGeneral atlanticTiger global managementBiospring partnersGeneral catalyst